JP2009523438A5 - - Google Patents

Download PDF

Info

Publication number
JP2009523438A5
JP2009523438A5 JP2008550832A JP2008550832A JP2009523438A5 JP 2009523438 A5 JP2009523438 A5 JP 2009523438A5 JP 2008550832 A JP2008550832 A JP 2008550832A JP 2008550832 A JP2008550832 A JP 2008550832A JP 2009523438 A5 JP2009523438 A5 JP 2009523438A5
Authority
JP
Japan
Prior art keywords
mesenchymal stem
msc
stem cells
fraction
tissue sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008550832A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009523438A (ja
Filing date
Publication date
Priority claimed from GBGB0600972.4A external-priority patent/GB0600972D0/en
Application filed filed Critical
Publication of JP2009523438A publication Critical patent/JP2009523438A/ja
Publication of JP2009523438A5 publication Critical patent/JP2009523438A5/ja
Pending legal-status Critical Current

Links

JP2008550832A 2006-01-18 2007-01-17 細胞の富化 Pending JP2009523438A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0600972.4A GB0600972D0 (en) 2006-01-18 2006-01-18 Enrichment of cells
PCT/GB2007/000107 WO2007083093A1 (en) 2006-01-18 2007-01-17 Enrichment of cells

Publications (2)

Publication Number Publication Date
JP2009523438A JP2009523438A (ja) 2009-06-25
JP2009523438A5 true JP2009523438A5 (enExample) 2010-03-04

Family

ID=36010490

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008550832A Pending JP2009523438A (ja) 2006-01-18 2007-01-17 細胞の富化

Country Status (7)

Country Link
US (1) US20100260721A1 (enExample)
EP (1) EP1979471A1 (enExample)
JP (1) JP2009523438A (enExample)
CN (1) CN101400786A (enExample)
AU (1) AU2007206750A1 (enExample)
GB (1) GB0600972D0 (enExample)
WO (1) WO2007083093A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3103463B1 (en) 2007-09-19 2020-01-01 Pluristem Ltd. Adherent cells from adipose or placenta tissues and use thereof in therapy
JP5645197B2 (ja) * 2009-06-23 2014-12-24 学校法人日本大学 幹細胞の未分化状態を維持する新規方法
JP2013507931A (ja) 2009-10-16 2013-03-07 ユニバーシティ オブ メディスン アンド デンティストリー オブ ニュー ジャージー 再生医療用途のための接着性骨髄幹細胞の閉鎖系統分離システム
SG10201408187XA (en) * 2009-12-22 2015-01-29 Agency Science Tech & Res Treatment of Bone Fracture
US20140314869A1 (en) * 2011-08-29 2014-10-23 Arnold I. Caplan Isolating and therapeutic use of perivascular medicinal cells
WO2013033777A1 (en) * 2011-09-09 2013-03-14 Mesoblast, Inc Methods for increasing osteoblastic function
CN103266081B (zh) * 2012-01-21 2015-05-13 中国人民解放军军事医学科学院附属医院 从脐带中分离培养间充质干细胞的高效方法
JP6452695B2 (ja) * 2013-08-06 2019-01-16 リジェネックス， エルエルシー 骨髄脂肪部分単離のデバイスおよび方法
EP2998392A1 (en) * 2014-09-16 2016-03-23 The Provost, Fellows, Foundation Scholars, & the other members of Board, of the College of the Holy & Undiv. Trinity of Queen Elizabeth near Dublin A population of cells for use in single-stage cell-based cartilage regeneration
TWI566774B (zh) * 2014-10-06 2017-01-21 佛教慈濟醫療財團法人花蓮慈濟醫院 治療關節疾病的組成物及其方法
WO2016111899A1 (en) 2015-01-05 2016-07-14 Petrucci Gary M Methods and materials for treating lung disorders
US20160193254A1 (en) * 2015-01-05 2016-07-07 Gary M. Petrucci Methods and materials for treating arthritis
WO2017136557A1 (en) 2016-02-05 2017-08-10 Petrucci Gary M Methods and materials for treating nerve injuries and neurological disorders
TWI689589B (zh) * 2016-08-31 2020-04-01 宣捷細胞生物製藥股份有限公司 區別間質幹細胞的方法及測定間質幹細胞的純度的方法
EP3739038A4 (en) * 2017-05-12 2021-03-31 National University Corporation Tokyo Medical and Dental University Method for purifying mesenchymal stem cells to improve transplantation efficiency
US10478531B2 (en) 2017-06-22 2019-11-19 Gary M. Petrucci Methods and materials for treating blood vessels
US10251917B1 (en) 2017-09-19 2019-04-09 Gary M. Petrucci Methods and materials for treating tumors
US11285177B2 (en) 2018-01-03 2022-03-29 Globus Medical, Inc. Allografts containing viable cells and methods thereof
WO2020161748A1 (en) * 2019-02-08 2020-08-13 Regrow Biosciences Private Limited Method for mesenchymal stem cell isolation and osteoblast differentiation
US11697799B2 (en) 2019-04-15 2023-07-11 Ossium Health, Inc. System and method for extraction and cryopreservation of bone marrow
EP4181675A4 (en) 2020-07-18 2024-04-24 Ossium Health, Inc. PERMEATION OF WHOLE VERTEBRATE BODIES WITH A CRYOPRETECTIVE AGENT USING VACUUM-ASSISTED DIFFUSION
CN116583594B (zh) 2020-10-14 2025-05-23 奥瑟姆健康公司 用于骨髓的提取和低温保藏的系统和方法
WO2022133282A1 (en) 2020-12-18 2022-06-23 Ossium Health, Inc. Methods of cell therapies
KR102858598B1 (ko) 2025-01-16 2025-09-10 신종인 콜라게나제를 이용한 지방세포 이식용 조성물의 제조방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811094A (en) * 1990-11-16 1998-09-22 Osiris Therapeutics, Inc. Connective tissue regeneration using human mesenchymal stem cell preparations
US5226914A (en) * 1990-11-16 1993-07-13 Caplan Arnold I Method for treating connective tissue disorders
US5486359A (en) * 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US6653134B2 (en) * 1995-03-28 2003-11-25 Cp Hahnemann University Isolated stromal cells for use in the treatment of diseases of the central nervous system
US6482231B1 (en) * 1995-11-20 2002-11-19 Giovanni Abatangelo Biological material for the repair of connective tissue defects comprising mesenchymal stem cells and hyaluronic acid derivative
ES2329953T3 (es) * 1996-04-19 2009-12-02 Osiris Therapeutics, Inc. Regeneracion e incremento de hueso utilizando celulas madre mesenquimales.
US6835377B2 (en) * 1998-05-13 2004-12-28 Osiris Therapeutics, Inc. Osteoarthritis cartilage regeneration
US6893900B1 (en) * 1998-06-24 2005-05-17 Amkor Technology, Inc. Method of making an integrated circuit package
US7670628B2 (en) * 1999-07-07 2010-03-02 Angioblast Systems, Inc. Mesenchymal precursor cell
DE60143517D1 (de) * 2000-04-25 2011-01-05 Osiris Therapeutics Inc Wiederherstellung der gelenken mit mesenchymalen stammzellen
CA2407696A1 (en) * 2000-04-28 2001-11-08 Children's Medical Center Corporation Isolation of mesenchymal stem cells and use thereof
US20030103947A1 (en) * 2001-02-23 2003-06-05 Urlich Noth In vitro engineered cartilage constructs produced by coating biodegradable polymer with human mesenchymal stem cells
WO2003101202A1 (en) * 2002-05-31 2003-12-11 Osiris Therapeutics, Inc. Intraperitoneal delivery of genetically engineered mesenchymal stem cells
AU2004252568B2 (en) * 2003-06-27 2011-06-30 Ethicon, Incorporated Regeneration and repair of neural tissue using postpartum-derived cells

Similar Documents

Publication Publication Date Title
JP2009523438A5 (enExample)
Ma et al. Cryopreserved dental pulp tissues of exfoliated deciduous teeth is a feasible stem cell resource for regenerative medicine
Schmelzer et al. Characterization of human mesenchymal stem cells from different tissues and their membrane encasement for prospective transplantation therapies
Cuthbert et al. Examining the feasibility of clinical grade CD271+ enrichment of mesenchymal stromal cells for bone regeneration
EP1845154A1 (en) Multipotent stem cells derived from placenta tissue and cellular therapeutic agents comprising the same
US20100260721A1 (en) Enrichment of Cells
US20100105132A1 (en) Human Mesenchymal stem cells and preparation thereof
EP3219790B1 (en) Myocardial cell sheet
Suszynska et al. The proper criteria for identification and sorting of very small embryonic-like stem cells, and some nomenclature issues
Nicoletti et al. Methods and procedures in adipose stem cells: state of the art and perspective for translation medicine
Mehrabani et al. Growth kinetics, characterization, and plasticity of human menstrual blood stem cells
Mabuchi et al. Prospective isolation of resident adult human mesenchymal stem cell population from multiple organs
Attar et al. Role of CD 271 enrichment in the isolation of mesenchymal stromal cells from umbilical cord blood
Enciso et al. Stem cell factor supports migration in canine mesenchymal stem cells
WO2014036094A1 (en) Isolation of stromal vascular fraction from adipose tissue obtained using homogenization with beads
US11613733B2 (en) Method for purifying mesenchymal stem cells to improve transplantation efficiency
Fracaro et al. Mesenchymal stromal cells derived from exfoliated deciduous teeth express neuronal markers before differentiation induction
Jia et al. Magnetic-activated cell sorting strategies to isolate and purify synovial fluid-derived mesenchymal stem cells from a rabbit model
Gowri et al. Foetal stem cell derivation & characterization for osteogenic lineage
Alvarez-Viejo et al. LNGFR (CD271) as marker to identify mesenchymal stem cells from different human sources: Umbilical cord blood, Wharton’s jelly and bone marrow
Anil et al. Isolation, culture, and characterization of dental pulp stem cells from human deciduous and permanent teeth
US20200345782A1 (en) Stem cell subpopulations with differential gstt1 expression or genotype
CN102864123A (zh) 一种外周血间充质干细胞的获得方法及其应用
JP2023549804A (ja) 老化が減少し、幹細胞能が保存された初期間葉系幹細胞及びその培養方法
Algraittee et al. Generation and Characterization of Human Osteoarthritis Cartilage-derived Mesenchymal Stem Cells by Modified Sample Processing and Culture Method.